AlphaYouFL
Schedule 13D filing
Frazier Life Sciences X, L.P. disclosed a 8.7% stake in NewAmsterdam Pharma Co N.V. (NAMS)
Frazier Life Sciences X, L.P. reported owning 8.7% of NewAmsterdam Pharma Co N.V. (NAMS) (10,424,224 shares) in a Schedule 13D filed Sep 22, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Sep 22, 2026
- Source
- Schedule 13D
More NAMS insider and Congress trades
From a public Schedule 13D, linked above. Not investment advice, and not a recommendation to buy or sell.